Rectal suppositories (suppositories) Salofalk are indicated for the treatment of exacerbations and the prevention of recurrence of ulcerative colitis limited to the rectum.
Active substance: mesalazine;
1 suppository contains 1000 mg of mesalazine (5-aminosalicylic acid);
Excipients: solid fat.
Hypersensitivity to mesalazine, to any of the components of the preparation or to salicylates, gastric ulcer and duodenal ulcer in the acute stage, severe hepatic and / or renal failure, hemorrhagic diathesis.
This medicinal product is intended for rectal administration.
Salofalk suppositories are applied preferably in the evening before bedtime.
The desired therapeutic result can be achieved only with the regular and constant use of Salofalk suppositories.
The duration of use is determined by the doctor.
Pregnant
Should be taken during pregnancy only when the expected benefit outweighs the potential risk.
Drivers
In cases where dizziness is observed during treatment, you should refrain from driving and working with mechanisms.
There are data on cases of overdose (for example, willful committing suicide with a high oral dose of mesalazine), do not indicate renal or hepatic toxicity. To date, no cases of intoxication and specific antidotes have been reported. There is no specific antidote; treatment should be symptomatic and supportive. If necessary, electrolyte infusion (forced diuresis) is used.
Adverse reactions most often observed in clinical studies: diarrhea, nausea, stomach pain, headache, vomiting and rash. Hypersensitivity reactions have sometimes developed.
Special studies of preparation interactions have not been conducted.
Keep out of the reach of children.
Store at a temperature not exceeding 30 ° C.
Store in original packaging to protect from light.
Shelf life is 3 years.
There are no reviews for this product.